Posted May 4, 2017
David Michael Holtzman, M.D. will share new insights about the disease pathology and the opportunities and challenges facing the Alzheimer’s scientific research community.
The presentation will be followed by a Q&A. If we are unable to address your question during the live conference, we will post answers to any remaining questions to this page.
If you wish to participate, please RSVP to Connor Swan at [email protected], or (781) 237-3800.
Instructions for Participation
This presentation will be broadcast via WebEx. To view the presenter slides and ask questions, you will need to join online. Online users will have the option to receive audio over the phone or through their computer. If you wish to participate by phone only, instructions are below under “Joining Audio Only”.
Joining Online
We recommend logging in at least 5 minutes prior to the event to ensure you do not miss any of the presentation. We will be starting promptly at 3:30 PM ET.
*Please be aware that if this is your first time using WebEx, your device may need to download the WebEx application. If you do not often use WebEx, we suggest clicking on the Run a Temporary Application link after logging in. This will download a file which, when opened, brings you directly into the presentation.
Joining Audio Only
Please note that Audio Only attendees will not be able to ask questions during the live Q&A.
How to Participate in the Q&A Portion of the Presentation
You may submit questions at any time during the presentation. We will answer as many as possible at the end of the program.
If you are unable to join the live conference, a recording will be available after the fact.
About Dr. Holtzman
The Andrew B. and Gretchen P. Jones Professor of Neurology; Head, Department of Neurology, Washington University, St. Louis
Charlotte and Paul Hagemann Professor of Neurology and Molecular Biology and Pharmacology
Associate Director, Alzheimer’s Disease Research Center
Scientific Director, Hope Center for Neurological Disorders
In addition to his laboratory, administrative and teaching duties, Dr. Holtzman is involved in clinical and research activities at the Washington University Memory and Aging Project and the Alzheimer’s Disease Research Center. Dr. Holtzman has carried out ground-breaking studies of molecules involved in beta-amyloid (Aβ) metabolism (such as apoE) and the initiation of Alzheimer’s pathology and the role of vascular factors such as amyloid angiopathy in the disease. He also has contributed greatly to our understanding of how anti-amyloid antibodies affect Alzheimer’s pathology and how Aβ is cleared from the brain of Alzheimer’s disease patients.
About the Catalyst Society
The Catalyst Society is a select group of donors to Cure Alzheimer’s Fund who are catalyzing the groundbreaking research that is moving us closer to preventing, slowing or reversing Alzheimer’s disease.
